INTRODUCTIONThe most common risk factors of chronic kidney disease are diabetes and hypertension. Preventing chronic kidney disease and early diagnosis of kidney damage are an important goal in primary health care. According to the Korea Health Insurance Review and Assessment Service, the number of Korean patients with chronic kidney disease increased by 37.1%, and total medical expenses increased by 47.6%, from 2006 to 2010. The average annual growth rate for the 5‐year period is of about 8.2% and 10.2%, respectively. According to the 2012 data, the total expenses for medical treatment of patients with end‐stage renal failure is similar to those of all cancer patients, and the expenses of medical treatment per patient are the highest among all diseases. Therefore, in patients with a high potential risk of kidney function, it is essential to periodically monitor the kidney function and to treat the progressive slowing down of the renal function as early as possible. An increased excretion of urinary protein, especially albumin, is an early finding of renal damage, and measurement of urinary albumin has been a useful marker for diagnosis and follow‐up of renal failure with estimated glomerular filtration rate. The urine albumin/creatinine ratio (ACR) test is also
Journal of Clinical Laboratory Analysis – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera